Asset
Brimonidine tartrate
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT03785340 | phase3 | completed | 2018-12-03 | 2019-02-25 | Ocugen | Study of Brimonidine Tartrate Nanoemulsion Eye Drop Solution in the Treatment of Dry Eye Disease (DED) |
| NCT03591874 | phase3 | terminated | 2018-12-23 | 2020-04-30 | Ocugen | Study of Brimonidine Tartrate Nanoemulsion Eye Drops in Patients With Ocular Graft-vs-Host Disease |
FDA applications (0)
This company has no applications containing this asset.